HEALTH COACH - HIV survival is virtually comparable to a healthy population with antiretroviral drugs

HEALTH COACH -

 HIV survival is virtually comparable to a healthy population with antiretroviral drugs  
 
 HIV has already been considered a death sentence but now thanks to new innovations in treatment and Drugs, HIV-positive people have life expectancies close to normal. This is the conclusion of a recent study by the University of Bristol, which gives the hope that, at least until we find out how to cure the virus, we can Be able to control it. 
 The study, Published online in  The Lancet  found that young people living with HIV who started their antiretroviral treatment in 2010 should live 10 years longer than those who Began using it in 1996  The BBC  reported. This success is based on newer drugs with fewer side effects and being more effective in preventing HIV from reproducing in the body. The study also found that starting treatment at the onset of the initial infection was important to ensure a long healthy life. This is especially important because many HIV-positive people still do not know their infection status. 
    Read:    Cura against the HIV 2017? New research suggests a way to theoretically eliminate the body's virus  
 
 The study combined data from 18 European and North American HIV-positive groups that participated in The Antiretroviral Therapy Cohort Collaboration (ART-CC). These individuals were all 16 years of age or older and had begun to treat three or more antiretroviral drugs between 1996 and 2010. In total, the study included information from 88,504 HIV-positive individuals. The results showed that people who started treatment from 2008 to 2010 were less likely to die compared to those who started their diet between 1996 and 2009. In the end, An HIV - positive patient who started antiretroviral therapy at the age of 20 years after 2008 was 78 years old, an age almost equal to that of the general public, reported the BBC. Tablets "title =" tablets "/>  [1945901]